Open forum infectious diseases

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents.

Open forum infectious diseases

Delagrèverie HM, Delaugerre C, Lewin SR, Deeks SG, Li JZ

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis.

Open forum infectious diseases

Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D

Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.

Open forum infectious diseases

Juliano JJ, Barnett E, Parobek CM, Taylor SM, Meshnick SR, Stone S, Chang E, Fong S, Huang L

Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial.

Open forum infectious diseases

Mupfumi L, Makamure B, Chirehwa M, Sagonda T, Zinyowera S, Mason P, Metcalfe JZ, Mutetwa R

1607Veterans Aging Cohort Study (VACS) Index, Functional Status, and Other Patient Reported Outcomes in Older HIV-positive (HIV+) Adults.

Open forum infectious diseases

Malcolm John, Nancy Hessol, C. Bradley Hare, Catherine Lyons, Roland Zepf, Terrence Marcotte, Amanda Hutton Parrott, Robert Whirry, Cameron Foreman, Monica Gandhi, Meredith Greene

Pages